Docstoc

Osteoarthritis _OA_ Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2019

Document Sample
Osteoarthritis _OA_ Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Powered By Docstoc
					Osteoarthritis (OA) Pain Therapeutics - Pipeline Assessment and Market
Forecasts to 2019

GlobalData, the industry analysis specialist, has released its new report, “Osteoarthritis
(OA) Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report is
an essential source of information and analysis on the global Osteoarthritis Pain
Therapeutics market. The report identifies the key trends shaping and driving the global
Osteoarthritis Pain Therapeutics market. The report also provides insights on the prevalent
competitive landscape and the emerging players expected to significantly alter the market
positioning of the current market leaders. Most importantly, the report provides valuable
insights on the pipeline products within the global Osteoarthritis Pain Therapeutics sector.
This report is built using data and information sourced from proprietary databases,
primary and secondary research and in-house analysis by GlobalData’s team of industry
experts.

Scope
The report provides information on the key drivers and challenges of the Osteoarthritis
Pain Therapeutics market. Its scope includes -
- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan)
Osteoarthritis Pain Therapeutics market revenues data from 2006 to 2011, forecast for
eight years to 2019.
- Pipeline analysis data providing a split across the different phases, mechanisms of action
being developed and emerging trends by seven key markets. Pipeline candidates fall under
major therapeutic classes.
- Analysis of the current and future competition in the seven key countries Osteoarthritis
Pain Therapeutics market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is
independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization,
unmet needs and the implications for the Osteoarthritis Pain Therapeutics market.
- Analysis of key recent licensing and partnership agreements in Osteoarthritis Pain
Therapeutics market

Get more information of this report @ http://www.reportsnreports.com/reports/167923-
osteoarthritis-oa-pain-therapeutics-pipeline-assessment-and-market-forecasts-to-2019.html

Reasons to buy
The report will enhance your decision making capability. It will allow you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products
and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global Osteoarthritis
Pain Therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market
segments and companies likely to impact the global Osteoarthritis Pain Therapeutics market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by
analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-
strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that
present maximum opportunities for consolidations, investments and strategic partnerships.
- What’s the next big thing in the global Osteoarthritis Pain Therapeutics market landscape? – Identify,
understand and capitalize.

Report Details:
Published: June 2012
No. of Pages: 98
Price: Single User License: US $ 3995   Corporate User License: US $ 11985




Major points covered in Table of Contents of this report include:
List of Tables 5
1.2 List of Figures 6
2 Osteoarthritis Pain Therapeutics - Introduction 7
2.1 Disease Overview 7
2.1.1 Classification of Osteoarthritis 8
2.1.2 Types of Osteoarthritis 8
2.1.3 Osteoarthritis Pain 13
2.2 Epidemiology 13
2.2.1 Prevalence 13
2.3 Quality of Life 14
2.4 Etiology 14
2.5 Signs and Symptoms 16
2.6 Diagnosis 16
2.6.1 Physical Examination 16
2.6.2 Radiological Examination 17
2.6.3 Laboratory Test 18
2.7 Pathophysiology 19
2.7.1 Progression of the Disease 19
2.8 Treatment and Management Options 20
2.8.1 Pharmacological treatment 24
2.9 Referral Pathway 27
2.10 GlobalData Pipeline Report Guidance 29
3 Osteoarthritis Pain Therapeutics - Market Characterization 30
3.1 Overview 30
3.2 Osteoarthritis Pain Therapeutics Market Size (2006-2011) – Global 31
3.3 Osteoarthritis Pain Therapeutics Market Forecast (2011-2019) – Global 32
3.4 Osteoarthritis Pain Therapeutics Market Size (2006-2011) – The US 33
3.5 Osteoarthritis Pain Therapeutics Market Forecast (2011-2019) – The US 34
3.6 Osteoarthritis Pain Therapeutics Market Size (2006-2011) – France 35
3.7 Osteoarthritis Pain Therapeutics Market Forecast (2011-2019) – France 36
3.8 Osteoarthritis Pain Therapeutics Market Size (2006-2011) – Germany 37
3.9 Osteoarthritis Pain Therapeutics Market Forecast (2011-2019) – Germany 38
3.10 Osteoarthritis Pain Therapeutics Market Size (2006-2011) – Italy 39
3.11 Osteoarthritis Pain Therapeutics Market Forecast (2011-2019) – Italy 40
3.12 Osteoarthritis Pain Therapeutics Market Size (2006-2011) – Spain 41
3.13 Osteoarthritis Pain Therapeutics Market Forecast (2011-2019) – Spain 42
3.14 Osteoarthritis Pain Therapeutics Market Size (2006-2011) – The UK 43
3.15 Osteoarthritis Pain Therapeutics Market Forecast (2011-2019) – The UK 44
3.16 Osteoarthritis Pain Therapeutics Market Size (2006-2011) – Japan 45
3.17 Osteoarthritis Pain Therapeutics Market Forecast (2011-2019) – Japan 46
3.18 Drivers and Barriers for the Osteoarthritis Pain Therapeutics Market 47
3.18.1 Drivers for the Osteoarthritis Pain Therapeutics Market 47
3.18.2 Barriers for the Osteoarthritis Pain Therapeutics Market 48
3.19 Opportunity and Unmet Need Analysis 49
3.20 Key Takeaway 50
4 Osteoarthritis Pain Therapeutics - Competitive Assessment 51
4.1 Overview 51
4.2 Strategic Competitor Assessment 51
4.3 Product Profiles for the Major Marketed Products in the Osteoarthritis Pain Therapeutics Market 53
4.3.1 Celebrex (celecoxib) 53
4.3.2 Voltaren Gel (diclofenac sodium) 53
4.3.3 Hyalgan (sodium hyaluronate) 54
4.3.4 Cymbalta (duloxetine) 54
4.3.5 Synvisc (hylan G-F 20) 55
4.4 Key Takeaway 56
5 Osteoarthritis Pain Therapeutics - Pipeline Assessment 57
5.1 Overview 57
5.2 Strategic Pipeline Assessment 57
5.3 Osteoarthritis Pain Therapeutics Pipeline – Pipeline by Phases of Development 58
5.3.1 Osteoarthritis Pain Therapeutics – Regulatory Filed Products 58
5.3.2 Osteoarthritis Pain Therapeutics – Phase III Pipeline 59
5.3.3 Osteoarthritis Pain Therapeutics – Phase II/III Pipeline 59
5.3.4 Osteoarthritis Pain Therapeutics – Phase II Pipeline 60
5.3.5 Osteoarthritis Pain Therapeutics – Phase I/II Pipeline 60
5.3.6 Osteoarthritis Pain Therapeutics – Phase I Pipeline 61
5.3.7 Osteoarthritis Pain Market – Discovery and Pre-Clinical Pipeline 61
5.3.8 Technology Trends Analytic Framework 62
5.4 Osteoarthritis Pain Therapeutics Market –Pipeline by Mechanism of Action 64
5.5 Molecule Profile for Promising Drugs Under Development 65
5.5.1 2 PX 65
5.5.2 Civanex 66
5.5.3 BEMA 67
5.5.4 CEP-33237 67
5.6 Key Takeaway 67
6 Osteoarthritis Pain Therapeutics - Clinical Trials Mapping 68
6.1 Clinical Trials by Region/Country (the US, EU5 and Japan) 68
6.2 Clinical Trials by Phase 69
6.3 Clinical Trials by Trial Status 70
6.4 Prominent Sponsors 71
6.5 Top Companies Participating in OA Pain Therapeutics Clinical Trials 73
7 Strategic Assessment 74
7.1 Key Events Impacting the Future Market 74
7.2 Osteoarthritis Pain Therapeutics: Implications for Future Market Competition 75
8 Osteoarthritis Pain Therapeutics - Future Players 76
8.1 Introduction 76
8.2 Company Profiles 77
8.2.1 Winston Pharmaceuticals, Inc. 77
8.2.2 Teva Pharmaceuticals 77
8.2.3 Pfizer, Inc. 79
8.2.4 SantoSolvo AS 81
8.2.5 BioDelivery Sciences International, Inc. 82
8.2.6 Savient Pharmaceuticals, Inc. 83
8.2.7 Eli Lilly and Company 84
8.2.8 Horizon Pharma 85
8.2.9 Boehringer Ingelheim 85
9 Osteoarthritis Pain Therapeutics - Licensing and Partnership Deals 87
10 Osteoarthritis Pain Therapeutics - Appendix 88
10.1 Market Definitions 88
10.2 Abbreviations 88
10.3 Bibliography 89
10.4 Methodology 91
10.4.1 Coverage 91
10.4.2 Secondary Research 91
10.4.3 Forecasting 92
10.4.4 Primary Research 94
10.4.5 Expert Panel Validation 95
10.5 Contact Us 95
10.6 Disclaimer 95

Related Reports @ http://www.reportsnreports.com/publisher/globaldata/
Contact:
TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252.
Tel: + 1 888 391 5441
sales@reportsandreports.com

Connect With Us:

				
DOCUMENT INFO
Shared By:
Categories:
Tags:
Stats:
views:20
posted:6/22/2012
language:
pages:5